Transcatheter Pulmonary Valve (TPV) Therapy Market to Witness Notable Growth by 2028

Comments · 400 Views

The global transcatheter pulmonary Valve therapy market was valued at USD 56.45 Billion in 2020 and is expected to reach USD 98.63 Billion by year 2028, at a CAGR of 7.25 percent.

According to the current analysis of Reports and Data, the global Transcatheter Pulmonary Valve (TPV) Therapy Market was valued at USD 56.45 Billion in 2020 and is expected to reach USD 98.63 Billion by the year 2028, at a CAGR of 7.25 percent. Transcatheter Pulmonary Valve (TPV) Therapy has come up as the treatment of choice in most congenital heart disease patients with degeneration of a previous right ventricular outflow tract repair. To avoid the need for repeat median sternotomy procedures, less invasive catheter-based interventions to treat pulmonary valve dysfunction have been developed over time.

The global market is driven by the rising incidence of congenital heart diseases and increasing awareness associated with TPV Therapy. For instance, in the United States, the incidence of congenital heart defects ranges between 4 to10 cases per 1,000, clustering around 8 cases per 1,000 live births. Continental variations in birth prevalence have been observed, from about 6.9 cases per 1000 births in Europe to 9.3 cases per 1000 births in Asia. However, the relationship between valve size and balloon waist may reflect selection and procedural bias, which is likely to hinder the market growth

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/1067

Further key findings from the report suggest

  • Transcatheter Pulmonary Valve (TPV) Therapy market is rising at a high growth rate of 7.25 percent in Asia Pacific followed by North America and Europe. High incidence of cardiovascular diseases will drive the demand for the market during forecast period across all regions.
  • The valuation for balloon expanded transcatheter Valve market was USD 56.45 Billion in 2020 and is expected to grow to USD 98.63 Billionby 2028. Benefits associated with transcatheter pulmonary Valve is the key factor supporting the increasing adoption of the theraphy and consequently contributing to the market growth.
  • Asia Pacific is expected to witness a CAGR of 12.9 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth
  • Regional reimbursement scenario is another key regulatory factor for adoption and growth of Transcatheter Pulmonary Valve (TPV) Therapy in the region..

Competitive Outlook of the Global Transcatheter Pulmonary Valve (TPV) Therapy Market

The globla Transcatheter Pulmonary Valve (TPV) Therapy market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Transcatheter Pulmonary Valve (TPV) Therapy market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report

Medtronic, Edward Lifesciences, Cryolife Inc, and Venus Medtech.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1067

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Transcatheter Pulmonary Valve (TPV) Therapy Market Segmentation:

Type (Revenue, USD Million; 2018–2028)

  • Balloon expanded
  • Self-expanded Transcatheter Valve

Application Outlook (Revenue, USD Million; 2018–2028)

  • Hospitals
  • Cardiology Centers
  • Others

Geographic Segment Covered in the Report:

The Transcatheter Pulmonary Valve (TPV) Therapy report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)

  • Europe (UK, Germany, France and the rest of Europe)

  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)

  • Latin America (Brazil, Mexico, and the rest of Latin America)

  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1067

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Infrared Imaging Market @ https://www.biospace.com/article/increased-use-for-security-and-surveillance-in-healthcare-industry-is-expected-to-drive-infrared-imaging-market-revenue-growth-in-near-future-reports-and-data/

Zotepine Market @ https://www.biospace.com/article/zotepine-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2028/

Hematology Instrument Market @ https://www.biospace.com/article/hematology-instrument-market-growth-global-survey-analysis-share-company-profiles-and-forecast-by-2028/

Urinary Stone Treatment Device Market @ https://www.biospace.com/article/urinary-stone-treatment-device-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/

Gynecological Devices Market @ https://www.biospace.com/article/gynecological-devices-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/

Cryptococcosis Market @ https://www.biospace.com/article/cryptococcosis-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Comments